Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.
Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.
The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.
The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.
Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.
Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.
Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.
Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.
Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.
Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.
Envista Holdings Corporation (NYSE: NVST) reported a 1.4% increase in sales to $660.8 million for Q4 2022, with core sales growth of 2.3% year-over-year. Net income reached $73.5 million, or $0.42 per diluted share, while adjusted net income rose to $91.9 million ($0.52 per diluted share), up from $81.1 million ($0.46) in Q4 2021. Adjusted EBITDA was $138.3 million, compared to $120.7 million the previous year. For 2023, Envista anticipates low-single digit core sales growth and an adjusted EBITDA margin exceeding 20%.
On January 30, 2023, Envista Holdings Corporation (NYSE: NVST) announced an Investor Access Event scheduled for February 24, 2023, from 8:00 am to 10:00 am PT at the Envista Summit. This hybrid event will feature a management presentation followed by a Q&A session. The Envista Summit aims to provide dental professionals with premium training across specialties like implantology, orthodontics, and endodontics, alongside digital dentistry training. For further details, visit the Envista Summit website.
Envista Holdings Corporation (NYSE: NVST) is set to report its fourth quarter 2022 financial results on February 8, 2023. A conference call to discuss these results will begin at 2:00 PM PT, lasting approximately one hour. The call will be accessible via the company's website, and a replay will be available shortly after. Envista, recognized for its extensive range of dental brands like Nobel Biocare and Ormco, focuses on enhancing patient care with innovative dental solutions and technologies, making it a significant player in the global dental products market.
Envista Holdings Corporation (NYSE: NVST) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, from 3:00 – 3:40 PM PT at the Westin St. Francis Hotel in San Francisco. Investors can access a live audio webcast and recording on Envista's Investor Relations website for 30 days post-event. Envista is a leading global dental products company with a portfolio of over 30 trusted dental brands, including Nobel Biocare and Ormco, focused on improving lives through innovative dental solutions and technology.
On November 7, 2022, Envista Holdings Corporation (NYSE: NVST) announced its upcoming participation in the Evercore ISI 5th Annual HEALTHCONx Conference. The virtual event will take place on November 30, 2022, from 11:20 AM to 12:05 PM ET. Investors can access live streams and recordings via Envista's Investor Relations website under Events and Presentations. Envista, a leading global dental products company, offers a diverse portfolio including dental implants, orthodontics, and digital imaging technologies, aimed at enhancing patient care.
Envista Holdings Corporation (NYSE: NVST) reported a 3.9% increase in sales for Q3 2022, totaling $631.1 million. Core sales growth stood at 4.9% compared to Q3 2021. Net income reached $49.6 million, translating to $0.28 per diluted share, while adjusted net income improved to $82.5 million or $0.47 per diluted share. Adjusted EBITDA rose to $127.6 million, reflecting a 20.2% margin. Despite economic challenges, the company maintains its guidance for mid-single-digit core sales growth and a 20% adjusted EBITDA margin for 2022.
Envista Holdings Corporation (NYSE: NVST) announced its participation in the Jefferies London Healthcare Conference on November 17, 2022, from 9:45 - 10:15 AM GMT. Investors can access audio recordings of the event via the Investor Relations section on Envista's website. Envista, a leading global dental products company with over 30 renowned brands, focuses on enhancing patient care through innovative solutions and services.
Envista Holdings Corporation (NYSE: NVST) will announce its third quarter 2022 financial results on November 3, 2022. A conference call is scheduled for the same day at 2:00 PM PT, expected to last approximately one hour. The results and related materials will be available on the company's website prior to the call. Envista is a global leader in dental products, encompassing more than 30 trusted brands and providing a comprehensive range of dental solutions.
FAQ
What is the current stock price of Envista Holdings Corporation (NVST)?
What is the market cap of Envista Holdings Corporation (NVST)?
What does Envista Holdings Corporation do?
What are the main segments of Envista's business?
What recent achievements has Envista made?
How did Envista perform financially in the first quarter of 2024?
What is the Envista Smile Project?
Who is the new CEO of Envista Holdings Corporation?
How does Envista support dental professionals?
What is the DEXIS digital ecosystem?
What is the Envista Business System (EBS)?
Where can I find more information about Envista Holdings Corporation?
